These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 17245715

  • 1. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J.
    J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
    [Abstract] [Full Text] [Related]

  • 2. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM.
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [Abstract] [Full Text] [Related]

  • 3. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 4. Immune response after influenza vaccination in children with cancer.
    Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T.
    Pediatr Blood Cancer; 2005 Nov; 45(6):831-7. PubMed ID: 16007602
    [Abstract] [Full Text] [Related]

  • 5. Debate on annual influenza vaccination in healthcare workers for the same subtype under the vaccine shortage.
    Song JY, Ha SH, Kee SY, Jeong HW, Cheong HJ, Kim WJ.
    J Clin Virol; 2007 Feb; 38(2):149-52. PubMed ID: 17196876
    [Abstract] [Full Text] [Related]

  • 6. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W.
    Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661
    [Abstract] [Full Text] [Related]

  • 7. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730
    [Abstract] [Full Text] [Related]

  • 8. Antibody responses after dose-sparing intradermal influenza vaccination.
    Auewarakul P, Kositanont U, Sornsathapornkul P, Tothong P, Kanyok R, Thongcharoen P.
    Vaccine; 2007 Jan 08; 25(4):659-63. PubMed ID: 17011678
    [Abstract] [Full Text] [Related]

  • 9. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.
    Zhu H, Ding X, Chen X, Yao P, Xu F, Xie R, Yang Z, Liang W, Zhang Y, Li Y, Shen J, He P, Guo Z, Su B, Sun S, Zhu Z.
    Vaccine; 2011 Jul 26; 29(33):5421-3. PubMed ID: 21645575
    [Abstract] [Full Text] [Related]

  • 10. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, Yamaoka T, Kudo Y.
    Vaccine; 2008 May 23; 26(22):2700-5. PubMed ID: 18436353
    [Abstract] [Full Text] [Related]

  • 11. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 12. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S, Süss J, Oehring H, Schmidt J.
    Acta Virol; 1982 Dec 27; 26(6):466-73. PubMed ID: 6132540
    [Abstract] [Full Text] [Related]

  • 13. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ, Gussekloo J, Remmerswaal JE, Remarque EJ, Kroes AC.
    J Med Virol; 2009 May 27; 81(5):908-14. PubMed ID: 19319953
    [Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
    Kerzner B, Murray AV, Cheng E, Ifle R, Harvey PR, Tomlinson M, Barben JL, Rarrick K, Stek JE, Chung MO, Schödel FP, Wang WW, Xu J, Chan IS, Silber JL, Schlienger K.
    J Am Geriatr Soc; 2007 Oct 27; 55(10):1499-507. PubMed ID: 17908055
    [Abstract] [Full Text] [Related]

  • 15. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination.
    Vesikari T, Groth N, Karvonen A, Borkowski A, Pellegrini M.
    Vaccine; 2009 Oct 23; 27(45):6291-5. PubMed ID: 19840662
    [Abstract] [Full Text] [Related]

  • 16. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 23; 24(7):570-3. PubMed ID: 12975010
    [Abstract] [Full Text] [Related]

  • 17. Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence.
    Song JY, Cheong HJ, Hwang IS, Choi WS, Jo YM, Park DW, Cho GJ, Hwang TG, Kim WJ.
    Vaccine; 2010 May 21; 28(23):3929-35. PubMed ID: 20394719
    [Abstract] [Full Text] [Related]

  • 18. Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).
    Michiels B, Philips H, Coenen S, Denekens J, Van Royen P.
    Vaccine; 2006 Apr 12; 24(16):3145-52. PubMed ID: 16490288
    [Abstract] [Full Text] [Related]

  • 19. Serological response to influenza vaccine after hematopoetic stem cell transplantation.
    Yalçin SS, Kondolot M, Albayrak N, Altaş AB, Karacan Y, Kuşkonmaz B, Aksu S, Cetin M, Göker H, Yurdakök K, Uçkan D.
    Ann Hematol; 2010 Sep 12; 89(9):913-8. PubMed ID: 20119669
    [Abstract] [Full Text] [Related]

  • 20. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season.
    Pyhälä R, Ikonen N, Santanen R, Haanpää M, Visakorpi R, Jäppinen P, Valle M.
    J Med Virol; 2001 Nov 12; 65(3):584-9. PubMed ID: 11596097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.